Global data from 2017 show that sepsis affected 49 million people and was tied to 11 million deaths.
The Infectious Diseases Society of America (IDSA) and five other medical organizations are urging changes to a national set of care measures for sepsis patients, with the aim of reducing unnecessary antibiotic use in patients who may not need them.
US and Canadian researchers, writing in the Annals of Internal Medicine today, said they have determined that, among patients with severe manifestations of sepsis, initiation of empirical antimicrobial therapy significantly reduces the sensitivity of blood cultures drawn shortly after treatment began—underscoring the need for early diagnostic blood tests.
An international group of specialists from hospitals, research institutes, public health agencies, and diagnostics firms yesterday published a paper outlining the challenges to developing novel and rapid antibiotic susceptibility tests (ASTs). The consensus statement was published in Nature Reviews Microbiology.
People who inject recreational drugs are 16.3 times more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than people who do not inject drugs, according to data published today in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Reports (MMWR).
Four research teams from India receive awards for point-of-care diagnostic tests, 3 of them focused on sepsis.
A significant increase in cases of severe sepsis and septic shock within 90 days of hospital discharge was observed among patients exposed to antibiotics during their previous hospital stay, researchers with the Centers for Disease Control and Prevention reported today in Clinical Infectious Diseases.
Study shows no increase in hospitalized sepsis cases over a 5-year period.
The World Health Organization (WHO) yesterday said French officials have notified it of a fatal yellow fever case in a 43-year-old Brazilian woman in French Guiana whose vaccination status isn't known.
People who've had drug-resistant bacteria detected in their urine or feces have a higher risk of developing a drug-resistant bloodstream infection for several years afterward, according to a study presented yesterday at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
